IDEX Corporation: Is The Growth Momentum in Health and Science Technologies Here To Stay?

IDEX Corporation’s third quarter 2025 results and strategic direction reveal both opportunities and challenges. The company’s performance exceeded expectations, marked by organic order growth of 7% and sales growth of 5%, particularly driven by its Health & Science Technologies (HST) segment. Key drivers of HST’s momentum include growth in markets such as pharmaceutical, data centers, semiconductor consumables, and space and defense. The recent acquisition of Micro-LAM is poised to bolster IDEX’s capabilities in optics, enhancing their material shaping technology portfolio. Conversely, the Fluid & Metering Technologies (FMT) and Fire & Safety/Diversified Products (FSDP) segments presented a mixed picture. FMT exceeded expectations due to strong execution and pricing strategies, particularly in the municipal water market. Meanwhile, FSDP faced headwinds from sluggish equipment replenishment spending and funding uncertainties, with decreases in rescue tools and dispensing volumes, especially outside of the United States.